Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach (Q37113241)

18 August 2017

Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach (English)

1 reference

18 August 2017

1

Andreas Laupacis

1 reference

18 August 2017

J Michael Paterson

2

1 reference

18 August 2017

Muhammad Mamdani

series ordinal

3

1 reference

18 August 2017

Alaa Rostom

series ordinal

4

1 reference

18 August 2017

Geoffrey M Anderson

series ordinal

5

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Canadian Medical Association Journal

18 August 2017

1 reference

18 August 2017

169

1 reference

18 August 2017

11

1 reference

18 August 2017

1167-1170

1 reference

Look beyond budgets to the broader benefits

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

Drug policy: making effective drugs available without bankrupting the healthcare system.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

The role of databases in drug postmarketing surveillance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

The impact of combined inhaled bronchodilator therapy in the treatment of COPD.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

Adverse events associated with prescription drug cost-sharing among poor and elderly persons

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=264957

Physician characteristics in relation to cardiovascular drugs commonly prescribed for hypertension in Nova Scotia

27 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14638652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14638652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertension

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14638652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

18 August 2017

1 reference